Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

11.56
Delayed Data
As of Mar 24
 +0.20 / +1.76%
Today’s Change
7.20
Today|||52-Week Range
16.38
+16.53%
Year-to-Date
No recent news for Omeros Corp.

Today’s Trading

Previous close11.36
Today’s open11.40
Day’s range11.30 - 11.74
Volume344,407
Average volume (3 months)490,590
Market cap$506.6M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+17.50%
Earnings growth (this year)+25.05%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+208.07%
P/E ratioNM
Price/Sales9.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SCLNSciClone Pharmaceuti...+0.15+1.56%
ACHNAchillion Pharmaceut...-0.03-0.79%
RARXRa Pharmaceuticals I...0.000.00%
SCMPSucampo Pharmaceutic...-0.15-1.40%
Data as of 4:14pm ET, 03/24/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$41.6M
Annual profit (last year)-$66.7M
Net profit margin-160.38%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
CFO, Treasurer, Chief Accounting Officer &
VP
Michael A. Jacobsen
Corporate headquarters
Seattle, Washington

Forecasts


Search for Jobs